8 Aug 2022 , 02:55 PM
Net profit of Suven Pharmaceuticals rose 2.34% to Rs 107.54 crore in the quarter ended June 2022 as against Rs 105.08 crore during the previous quarter ended June 2021. Sales rose 28.43% to Rs 338.80 crore in the quarter ended June 2022 as against Rs 263.80 crore during the previous quarter ended June 2021.
Particulars | Quarter Ended | ||
? | Jun. 2022 | Jun. 2021 | % Var. |
Sales | 338.80 | 263.80 | 28 |
OPM % | 44.54 | 43.45 | – |
PBDT | 160.46 | 141.92 | 13 |
PBT | 148.96 | 132.92 | 12 |
NP | 107.54 | 105.08 | 2 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.